Search Results
Search for other papers by R Michael Tuttle in
Google Scholar
PubMed
Search for other papers by Duan Li in
Google Scholar
PubMed
Search for other papers by Fourat Ridouani in
Google Scholar
PubMed
Introduction For more than 40 years, the prevailing treatment paradigm for well-differentiated thyroid cancer endorsed total thyroidectomy, radioactive iodine therapy, and thyroid hormone suppressive therapy for most patients with papillary
Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
Endocrine Oncology Site, Princess Margaret Cancer Centre, Toronto, ON, Canada
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
Search for other papers by Ozgur Mete in
Google Scholar
PubMed
Search for other papers by Zubair W Baloch in
Google Scholar
PubMed
thyroid cancer is a multistep process involving both early driver changes as well as late event changes. The well-differentiated thyroid carcinomas (PTC and FTC) usually are BRAF - or RAS -driven ( Nikiforov 2004 , Cancer Genome Atlas Research Network
Search for other papers by Maria Riedmeier in
Google Scholar
PubMed
Search for other papers by Lester D R Thompson in
Google Scholar
PubMed
Search for other papers by Carlos Augusto Fernandes Molina in
Google Scholar
PubMed
Search for other papers by Boris Decarolis in
Google Scholar
PubMed
Search for other papers by Christoph Härtel in
Google Scholar
PubMed
Comprehensive Cancer Centre Mainfranken, University of Wuerzburg Medical Centre, Wuerzburg, Germany
Search for other papers by Paul-G Schlegel in
Google Scholar
PubMed
Department of Medicine, Division of Endocrinology and Diabetes, University Hospital, University of Wuerzburg, Wuerzburg, Germany
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Comprehensive Cancer Centre Mainfranken, University of Wuerzburg Medical Centre, Wuerzburg, Germany
Search for other papers by Verena Wiegering in
Google Scholar
PubMed
January 1987. The search strategy for PubMed was as follows: (‘child*’[Title/Abstract] OR ‘pediatric*’[Title/Abstract]) AND (‘cancer’[Title/Abstract] OR ‘carcinoma’[Title/Abs tract] OR ‘tumor’[Title/Abstract] OR ‘malign*’[Title/Abstract]) AND
Inserm U1016, CNRS UMR 8104, Institut Cochin, Université Paris Descartes-Université de Paris, Paris, France
Search for other papers by Chiara Villa in
Google Scholar
PubMed
Department of Neurosurgery, Hôpital Universitaire Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France
Search for other papers by Bertrand Baussart in
Google Scholar
PubMed
Department of Endocrinology, Center for Rare Adrenal Diseases, Hôpital Cochin APHP, Paris, France
Search for other papers by Guillaume Assié in
Google Scholar
PubMed
Lyon 1 University, Villeurbanne, France
Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Lyon, France
Search for other papers by Gerald Raverot in
Google Scholar
PubMed
Search for other papers by Federico Roncaroli in
Google Scholar
PubMed
the nomenclature of pituitary adenomas in 2016 ( Asa et al. 2017 ) and the controversy that followed ( Ho et al. 2019 , 2020 , 2021 , 2022 ), the WHO and International Agency for Research on Cancer (IARC) opted for the combined definition of